Perfluorinated compounds in babyfood products
EPTIS factsheet 981745 | Last revision 2022-11-23 | URL: https://www.eptis.bam.de/pts981745 https://www.eptis.bam.de/pts981745
| PT provider | ||||||||||||||||||||||||||||||||||
| PT provider | PROOF-ACS GmbH PROOF-ACS GmbH | |||||||||||||||||||||||||||||||||
| Based in | Germany | |||||||||||||||||||||||||||||||||
| Language(s) | English, German | |||||||||||||||||||||||||||||||||
| Remarks | EFSA derived a new TWI related to perfluorinated compounds in 2020. The TWI of 4.4 ng/kg bw per week applied to the sum of four perflourinated compounds (PFCs): perfluorooctane sulfonic acid (PFOS), perfluorooctanoic acid (PFOA), perflurononanoic acid (PFNA), and perflurorohexanesulfonic acid (PFHxS). All four PFCs are covered by this ring test. Two test materials are provided. A sample of infant formula as well as a sample of a ready-to-eat babyfood, which contains fish products. Both materials contain spiked and/or incurred levels of the four PFCs. The test is designed for low levels of PFCs in babyfood, thus LOQs of 0.3 µg/kg are required for all PFCs mentioned above. | |||||||||||||||||||||||||||||||||
| Keywords | ||||||||||||||||||||||||||||||||||
| Product groups | 
                    
                        Food and drink
                         | 
                |||||||||||||||||||||||||||||||||
| Testing fields | 
                    
                        Analytical chemistry
                         | 
                |||||||||||||||||||||||||||||||||
| Technical details | ||||||||||||||||||||||||||||||||||
                        
  | 
                ||||||||||||||||||||||||||||||||||
| Aims of the PT scheme | ||||||||||||||||||||||||||||||||||
| Target group of participants | ||||||||||||||||||||||||||||||||||
| Linked to specific legislation / standards | EFSA TWI perfluorinated compounds | |||||||||||||||||||||||||||||||||
| Additional, subsidiary aims | ||||||||||||||||||||||||||||||||||
| Number of participants | 10-20 | |||||||||||||||||||||||||||||||||
| Accredited or otherwise reviewed by a 3rd party | ||||||||||||||||||||||||||||||||||
| Operation is commissioned / requested by | ||||||||||||||||||||||||||||||||||
| Fees and frequency | ||||||||||||||||||||||||||||||||||
| Participation fee | 850 | |||||||||||||||||||||||||||||||||
| Regularly operated | No | |||||||||||||||||||||||||||||||||
| When will be the next round | 2024 | |||||||||||||||||||||||||||||||||
| Contact details of the PT provider | ||||||||||||||||||||||||||||||||||
| Provider | Contact person | |||||||||||||||||||||||||||||||||
| 
                        PROOF-ACS GmbH
                         Gottlieb-Daimler-Str. 1 28237 Bremen Germany Phone: +49 (0)421 388 928 50 Fax: Web: http://www.proof-acs.de http://www.proof-acs.de  | 
                    
                        Dr. Birgit Schindler
                         Phone: +49 (0)421 388 928 50 Fax: Email: proof@proof-acs.de proof@proof-acs.de  | 
                |||||||||||||||||||||||||||||||||